The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The role of CHFR as a predictive marker of response to taxane-based preoperative chemotherapy in triple-negative breast cancer.
Elisavet Paplomata
No relevant relationships to disclose
Gabriel Sica
No relevant relationships to disclose
Shahrzad Ehdaivand
No relevant relationships to disclose
Dana Nickleach
No relevant relationships to disclose
Yuan Liu
No relevant relationships to disclose
Amelia Bruce Zelnak
No relevant relationships to disclose
Ruth O'Regan
No relevant relationships to disclose
Johann Christoph Brandes
No relevant relationships to disclose